Loading…
Facilitating Innovation to Fight Coronavirus Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,086 other S bills in the 116th — cohort avg 30d
Facilitating Innovation to Fight Coronavirus Act This bill provides immunity from civil liability to health care providers for certain actions taken during the COVID-19 (i.e., coronavirus disease 2019) public health emergency and lengthens the terms of certain medical patents related to the treatment of COVID-19. Specifically, when testing for or treating COVID-19 during the public health emergency, a health care provider may not be held liable in any federal, state, or local civil proceeding for (1) using or modifying a medical device for an unapproved use or indication; (2) practicing without a license or outside of an area of specialty, if instructed to do so by an individual with such a license or within such an area of speciality; or (3) conducting the testing of, or providing treatment to, a patient outside of the premises of standard health care facilities. Additionally, certain medical patents that are issued with respect to the treatment of COVID-19 are deemed not to begin until the termination of the presidential emergency declaration relating to COVID-19 and are extended for an additional 10 years.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (8)
Read twice and referred to the Committee on the Judiciary.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2020 · fourth_quarter · Health Issues
General issues related to drug shortages General issues related to COVID-19 (S. 3630, S. 4317, H.R. 7528) General issues related to drug cost oversight General issues related to domestic manufacturing of pharmaceutical products Lower Health Care Costs Act (S. 1895) Lower Drug Costs Now Act (H.R. 3) Prescription Drug Pricing Reduction Act (S. 2543) CARES Act (H.R. 748) Families First Coronavirus Response Act (H.R. 6201) HEROES Act (H.R. 6800) H.R. 133 - Consolidated Appropriations Act, 2021 General issues related to the Public Health Services Act Strengthening Americas Strategic National Stockpile Act of 2020 (H.R. 7574) Preparing for the Next Pandemic Act (S. 4231)
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2020 · fourth_quarter · Health Issues
General issues related to drug shortages General issues related to COVID-19 (S 3630, S 4317, HR 7528) General issues related to drug cost oversight General issues related to domestic manufacturing of pharmaceutical products General issues related to the Public Health Services Act Lower Health Care Costs Act (S 1895) Lower Drug Costs Now Act (HR 3) Prescription Drug Pricing Reduction Act (S 2543) CARES Act (HR 748) Families First Coronavirus Response Act (HR 6201) HEROES Act (HR 6800) Strengthening America's Strategic National Stockpile Act of 2020 (HR 7574) Preparing for the Next Pandemic Act (S 4231)
Client expense: $285,896 · Firm income: Not reported
Government targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2020 · fourth_quarter · Labor Issues/Antitrust/Workplace
S.306 - A bill to promote merger enforcement and protect competition through adjusting premerger filing fees, increasing antitrust enforcement resources, and improving the information provided to antitrust enforcers (Amy Klobuchar, D-MN) S.1978 - A bill to ensure that persons who form corporations or limited liability companies in the United States disclose the beneficial owners of those corporations or limited liability companies, in order to prevent wrongdoers from exploiting United States corporations and limited liability companies for criminal gain, to assist law enforcement in detecting, preventing, and punishing terrorism, money laundering, and other misconduct involving United States corporations and limited liability companies, and for other purposes (Ron Wyden, D-OR) H.R.2749 - To prohibit forced arbitration in work disputes, and for other purposes (Jerrold Nadler, D-NY-10) H.R.1423 - Forced Arbitration Injustice Repeal Act (Hank Johnson, Jr., D-GA-4) S.610 - Forced Arbitration Injustice Repeal Act (Richard Blumenthal, D-CT) H.R.2474 - Protecting the Right to Organize Act of 2019 (Robert Bobby Scott, D-VA-3) H.R.5712 - To repeal the authority under the National Labor Relations Act for States to enact laws prohibiting agreements requiring membership in a labor organization as a condition of employment, and for other purposes (Brad Sherman, D-CA-30) Senate Version: S.3255 - A bill to repeal the authority under the National Labor Relations Act for States to enact laws prohibiting agreements requiring membership in a labor organization as a condition of employment, and for other purposes (Elizabeth Warren, D-MA) H.R.6664 - To educate businesses on COVID-19 based public health practices, to provide for a notice and cure period before the commencement of a private civil action, and for other purposes (Tim Burchett, R-TN-2) S.3630 - A bill to provide certain limitations on liability for actions taken by health care providers to combat COVID-19 (Ben Sasse, R-NE) H.R.6844 - To provide expanded unemployment protection for employees and a limitation on liability for employers with respect to exposure to COVID-19 (Michael Turner, R-OH-10) H.R.6976 - To provide liability protection for nonprofit organizations during the COVID-19 outbreak, and for other purposes (Vicky Hartzler, R-MO-4) H.R.6909 - To provide for the establishment of a COVID-19 Compensation Fund, and for other purposes (Carolyn Maloney, D-NY-12) S.3915 - A bill to exempt certain businesses from liability arising from claims relating to an individual contracting COVID-19 as a result of patronizing a business or healthcare entity (Kelly Loeffler, R-GA) H.R.7179 - To provide liability protection for covered providers during the COVID-19 outbreak, and for other purposes (Gregory Murphy, R-NC-3) S.3941 - A bill to reopen the United States by rescinding, modifying, waiving, or providing exemptions from regulations and other requirements that may inhibit economic recovery from the COVID-19 pandemic, and for other purposes (Kelly Loeffler, R-GA) H.R.7266 - To prohibit COVID-19 liability waiver enforceability for large indoor gatherings (Mark Pocan, D-WI-2) H.R.7528 - To limit the civil liability of persons for the spread or possible transmission of SARS-COV-2 caused by an act or omission while acting in good faith during the COVID-19 emergency period, and for other purposes (Garret Graves, R-LA-6) S.4317 - SAFE TO WORK Act (John Cornyn, R-TX) H.R.1418 - Competitive Health Insurance Reform Act of 2020 (Peter DeFazio, D-OR-4) H.R.8698 - To amend the Civil Rights Act of 1964 to clarify that disparate impacts on certain populations constitute a sufficient basis for rights of action under such Act, and for other purposes (Rashida Tlaib, D-MI-13)
Client expense: $470,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Highway Traffic Safety Administration (NHTSA), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
2020 · fourth_quarter · Copyright/Patent/Trademark
S. 2082/H.R. 3666 (STRONGER Patents Act) Trade-related intellectual property policy/practices/encroachment by foreign countries/companies against U.S. competitiveness interests - China, Committee on Foreign Investment in the United States review of Chinese acquisitions and joint ventures, United States-Mexico-Canada Agreement IP chapter, International Trade Commission exclusion of U.S. patent-infringing imports, ITC baseband chip set patent infringement remedy, intellectual property exclusivity and protections in trade agreements Piracy of online and streaming copyrighted content Compulsory licensing - S. 377/H.R. 1046 (Medicare Negotiation and Competitive Licensing Act), S. 102/H.R. 465 (Prescription Drug Price Relief Act), S. 977 (Transparent Drug Pricing Act) NIST Return on Investment Initiative for Unleashing American Innovation S. 344/H.R. 990 (Hatch-Waxman Integrity Act) FTC/patent licensing as exclusive property right Bayh-Dole Act/technology transfer, misuse of march-in rights Procedural and evidentiary standards used at Patent Trial and Appeal Board PTO patentable subject matter eligibility guidance Section 101 patentable subject matter reform Injunctive relief from willful infringement DOJ-DOC withdrawal of 2013 Policy Statement on Remedies for Standards-Essential Patents Subject to Voluntary F/RAND Commitments S. 1273/H.R. 2426 (Copyright Alternative in Small-Claims Enforcement (CASE) Act) S. 1416 (Affordable Prescriptions for Patients Act) Obviousness/No Combination Drug Patents Act H.R. 4398/H.R. 5133 (Affordable Prescriptions for Patients Through Promoting Competition Act) H.R. 3991 (Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act) H.R. 5478 (Inventor Rights Act) Patent licensing/standards-essential patents/U.S. technological leadership in 5G and other technologies/economic and national security implications DOJ-PTO-NIST 2019 revised Joint Statement on Remedies for Standards-Essential Patents Subject to Voluntary F/RAND Commitments Efficient infringement Digital Millennium Copyright Act modernization Patent Trial & Appeal Board Covered Business Methods program PTAB Rules of Practice for Instituting on All Challenged Patent Claims and All Grounds and Eliminating the Presumption at Institution Favoring Petitioner as to Testimonial Evidence (Docket No. PTO-P-2019-0024) S. 3630 (Facilitating Innovation to Fight Coronavirus Act) Denial of rights of exclusivity for COVID-19-related innovations H.R. 7366 (Restoring Americas Leadership in Innovation Act) S. 3835 (SCRIPT Act) Proposed policy requiring privately produced, privately funded, copyrighted, peer-reviewed journal articles be given away free upon publication if they discuss any underlying research supported by a government grant Patent Trial and Appeal Board Covered Business Methods program statutory expiration Appointments Clause and the constitutionality of AdministrativePatent Judges invalidation of patents Amendments to the Rules of Practice for Trials Before the Patent Trial and Appeal Board (RIN:0651-AD47) Discretion to Institute Trials Before the Patent Trial and Appeal Board (Docket No. PTO-C-2020-0055) H.R. 133 (Consolidated Appropriations Act FY 2021 provisions related to Patent & Trademark Office, CASE Act, and copyright infringement via streaming loophole reform)
Client expense: Not reported · Firm income: $10,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
2020 · third_quarter · Insurance
Pandemic Liability Protection; Federal Preemption Liability; Surety; Credit Enhancement; Business Interruption Insurance; CARES Act funding; Credit Risk Transfer issue; Covid-4 Package (liability issue). H.R. 748: The Coronavirus Aid, Relief, and Economic Security (CARES) Act S.3548: The Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 6800: Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act S.3630: The Facilitating Innovation to Fight Coronavirus Act H.R. 6664: The Coronavirus Public Safety and Economic Recovery Act H.R. 6601: To require a particular jury instruction in Federal civil actions that include a claim for damages based on negligence arising from the transmission of COVID-19 H.R. 6283: The Good Samaritan Health Professionals Act of 2020 H.R. 6359: Promoting Infrastructure by Protecting Our Subcontractors and Taxpayers Act S.1350: Good Samaritan Health Professionals Act of 2019 H.R. 6844: The Employer and Employee COVID Protection Act S.4317: Safe to Work Act H.R. __: The Employer and Employee COVID Protection Act (NO NUMBER) H.R.6201 - Families First Coronavirus Response Act H.R.6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R.266 - Paycheck Protection Program and Health Care Enhancement Act H.R.7819 - Eliminating the Provider Relief Fund Tax Penalties Act of 2020 H.R.7010 - Paycheck Protection Program Flexibility Act of 2020 H.R.6886 - Paycheck Protection Program Flexibility Act of 2020 S.3805 - Paycheck Protection Program Flexibility Act of 2020 S.3415 - Paid Sick Days for Public Health Emergencies and Personal and Family Care Act
Client expense: Not reported · Firm income: $30,000
Government targets: Federal Housing Finance Agency (FHFA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
2020 · third_quarter · Consumer Issues/Safety/Products
Pandemic Liability Protection; Federal Preemption Liability; Surety; Credit Enhancement; Business Interruption Insurance; CARES Act funding; Credit Risk Transfer issue; Covid-4 Package (liability issue). H.R. 748: The Coronavirus Aid, Relief, and Economic Security (CARES) Act S.3548: The Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 6800: Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act S.3630: The Facilitating Innovation to Fight Coronavirus Act H.R. 6664: The Coronavirus Public Safety and Economic Recovery Act H.R. 6601: To require a particular jury instruction in Federal civil actions that include a claim for damages based on negligence arising from the transmission of COVID-19 H.R. 6283: The Good Samaritan Health Professionals Act of 2020 H.R. 6359: Promoting Infrastructure by Protecting Our Subcontractors and Taxpayers Act S.1350: Good Samaritan Health Professionals Act of 2019 H.R. 6844: The Employer and Employee COVID Protection Act S.4317: Safe to Work Act H.R. __: The Employer and Employee COVID Protection Act (NO NUMBER) H.R.6201 - Families First Coronavirus Response Act H.R.6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R.266 - Paycheck Protection Program and Health Care Enhancement Act H.R.7819 - Eliminating the Provider Relief Fund Tax Penalties Act of 2020 H.R.7010 - Paycheck Protection Program Flexibility Act of 2020 H.R.6886 - Paycheck Protection Program Flexibility Act of 2020 S.3805 - Paycheck Protection Program Flexibility Act of 2020 S.3415 - Paid Sick Days for Public Health Emergencies and Personal and Family Care Act
Client expense: Not reported · Firm income: $30,000
2020 · third_quarter · Economics/Economic Development
Pandemic Liability Protection; Federal Preemption Liability; Surety; Credit Enhancement; Business Interruption Insurance; CARES Act funding; Credit Risk Transfer issue; Covid-4 Package (liability issue). H.R. 748: The Coronavirus Aid, Relief, and Economic Security (CARES) Act S.3548: The Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 6800: Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act S.3630: The Facilitating Innovation to Fight Coronavirus Act H.R. 6664: The Coronavirus Public Safety and Economic Recovery Act H.R. 6601: To require a particular jury instruction in Federal civil actions that include a claim for damages based on negligence arising from the transmission of COVID-19 H.R. 6283: The Good Samaritan Health Professionals Act of 2020 H.R. 6359: Promoting Infrastructure by Protecting Our Subcontractors and Taxpayers Act S.1350: Good Samaritan Health Professionals Act of 2019 H.R. 6844: The Employer and Employee COVID Protection Act S.4317: Safe to Work Act H.R. __: The Employer and Employee COVID Protection Act (NO NUMBER) H.R.6201 - Families First Coronavirus Response Act H.R.6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R.266 - Paycheck Protection Program and Health Care Enhancement Act H.R.7819 - Eliminating the Provider Relief Fund Tax Penalties Act of 2020 H.R.7010 - Paycheck Protection Program Flexibility Act of 2020 H.R.6886 - Paycheck Protection Program Flexibility Act of 2020 S.3805 - Paycheck Protection Program Flexibility Act of 2020 S.3415 - Paid Sick Days for Public Health Emergencies and Personal and Family Care Act
Client expense: Not reported · Firm income: $30,000
2020 · third_quarter · Disaster Planning/Emergencies
Pandemic Liability Protection; Federal Preemption Liability; Surety; Credit Enhancement; Business Interruption Insurance; CARES Act funding; Credit Risk Transfer issue; Covid-4 Package (liability issue). H.R. 748: The Coronavirus Aid, Relief, and Economic Security (CARES) Act S.3548: The Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 6800: Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act S.3630: The Facilitating Innovation to Fight Coronavirus Act H.R. 6664: The Coronavirus Public Safety and Economic Recovery Act H.R. 6601: To require a particular jury instruction in Federal civil actions that include a claim for damages based on negligence arising from the transmission of COVID-19 H.R. 6283: The Good Samaritan Health Professionals Act of 2020 H.R. 6359: Promoting Infrastructure by Protecting Our Subcontractors and Taxpayers Act S.1350: Good Samaritan Health Professionals Act of 2019 H.R. 6844: The Employer and Employee COVID Protection Act S.4317: Safe to Work Act H.R. __: The Employer and Employee COVID Protection Act (NO NUMBER) H.R.6201 - Families First Coronavirus Response Act H.R.6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R.266 - Paycheck Protection Program and Health Care Enhancement Act H.R.7819 - Eliminating the Provider Relief Fund Tax Penalties Act of 2020 H.R.7010 - Paycheck Protection Program Flexibility Act of 2020 H.R.6886 - Paycheck Protection Program Flexibility Act of 2020 S.3805 - Paycheck Protection Program Flexibility Act of 2020 S.3415 - Paid Sick Days for Public Health Emergencies and Personal and Family Care Act
Client expense: Not reported · Firm income: $30,000
2020 · third_quarter · Health Issues
General issues related to drug shortages General issues related to COVID-19 (S. 3630, S. 4317, H.R. 7528) General issues related to drug cost oversight General issues related to domestic manufacturing of pharmaceutical products Lower Health Care Costs Act (S. 1895) Lower Drug Costs Now Act (H.R. 3) Prescription Drug Pricing Reduction Act (S. 2543) CARES Act (H.R. 748) Families First Coronavirus Response Act (H.R. 6201) HEROES Act (H.R. 6800)
Client expense: Not reported · Firm income: $80,000
2020 · third_quarter · Health Issues
General issues related to drug shortages General issues related to COVID-19 (S 3630, S 4317, HR 7528) General issues related to drug cost oversight General issues related to domestic manufacturing of pharmaceutical products Lower Health Care Costs Act (S 1895) Lower Drug Costs Now Act (HR 3) Prescription Drug Pricing Reduction Act (S 2543) CARES Act (HR 748) Families First Coronavirus Response Act (HR 6201) HEROES Act (HR 6800) Strengthening America's Strategic National Stockpile Act of 2020 (HR 7574) Preparing for the Next Pandemic Act (S 4231)
Client expense: $336,505 · Firm income: Not reported
Government targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2020 · third_quarter · Health Issues
General issues related to drug shortages General issues related to COVID-19 (S. 3630, S. 4317, H.R. 7528) General issues related to drug cost oversight General issues related to domestic manufacturing of pharmaceutical products Lower Health Care Costs Act (S. 1895) Lower Drug Costs Now Act (H.R. 3) Prescription Drug Pricing Reduction Act (S. 2543) CARES Act (H.R. 748) Families First Coronavirus Response Act (H.R. 6201) HEROES Act (H.R. 6800)
Client expense: Not reported · Firm income: $80,000
2020 · third_quarter · Labor Issues/Antitrust/Workplace
S.306 - A bill to promote merger enforcement and protect competition through adjusting premerger filing fees, increasing antitrust enforcement resources, and improving the information provided to antitrust enforcers (Amy Klobuchar, D-MN) , ALL PROVISIONS S.1978 - A bill to ensure that persons who form corporations or limited liability companies in the United States disclose the beneficial owners of those corporations or limited liability companies, in order to prevent wrongdoers from exploiting United States corporations and limited liability companies for criminal gain, to assist law enforcement in detecting, preventing, and punishing terrorism, money laundering, and other misconduct involving United States corporations and limited liability companies, and for other purposes (Ron Wyden, D-OR) , ALL PROVISIONS H.R.2749 - To prohibit forced arbitration in work disputes, and for other purposes (Jerrold Nadler, D-NY-10) , ALL PROVISIONS H.R.1423 - Forced Arbitration Injustice Repeal Act (Hank Johnson, Jr., D-GA-4) , ALL PROVISIONS S.610 - Forced Arbitration Injustice Repeal Act (Richard Blumenthal, D-CT) , ALL PROVISIONS H.R.2474 - Protecting the Right to Organize Act of 2019 (Robert Bobby Scott, D-VA-3) , ALL PROVISIONS H.R.5712 - To repeal the authority under the National Labor Relations Act for States to enact laws prohibiting agreements requiring membership in a labor organization as a condition of employment, and for other purposes (Brad Sherman, D-CA-30) Senate Version: S.3255 - A bill to repeal the authority under the National Labor Relations Act for States to enact laws prohibiting agreements requiring membership in a labor organization as a condition of employment, and for other purposes (Elizabeth Warren, D-MA) , ALL PROVISIONS H.R.6664 - To educate businesses on COVID-19 based public health practices, to provide for a notice and cure period before the commencement of a private civil action, and for other purposes (Tim Burchett, R-TN-2) , ALL PROVISIONS S.3630 - A bill to provide certain limitations on liability for actions taken by health care providers to combat COVID-19 (Ben Sasse, R-NE) , ALL PROVISIONS H.R.6844 - To provide expanded unemployment protection for employees and a limitation on liability for employers with respect to exposure to COVID-19 (Michael Turner, R-OH-10) , ALL PROVISIONS H.R.6976 - To provide liability protection for nonprofit organizations during the COVID-19 outbreak, and for other purposes (Vicky Hartzler, R-MO-4) , ALL PROVISIONS H.R.6909 - To provide for the establishment of a COVID-19 Compensation Fund, and for other purposes (Carolyn Maloney, D-NY-12) , ALL PROVISIONS S.3915 - A bill to exempt certain businesses from liability arising from claims relating to an individual contracting COVID-19 as a result of patronizing a business or healthcare entity (Kelly Loeffler, R-GA) , ALL PROVISIONS H.R.7179 - To provide liability protection for covered providers during the COVID-19 outbreak, and for other purposes (Gregory Murphy, R-NC-3) , ALL PROVISIONS S.3941 - A bill to reopen the United States by rescinding, modifying, waiving, or providing exemptions from regulations and other requirements that may inhibit economic recovery from the COVID-19 pandemic, and for other purposes (Kelly Loeffler, R-GA) , ALL PROVISIONS H.R.7266 - To prohibit COVID-19 liability waiver enforceability for large indoor gatherings (Mark Pocan, D-WI-2) , ALL PROVISIONS H.R.7528 - To limit the civil liability of persons for the spread or possible transmission of SARS-COV-2 caused by an act or omission while acting in good faith during the COVID-19 emergency period, and for other purposes (Garret Graves, R-LA-6) , ALL PROVISIONS S.4317 - SAFE TO WORK Act (John Cornyn, R-TX) , ALL PROVISIONS
2020 · third_quarter · Copyright/Patent/Trademark
S. 2082/H.R. 3666 (STRONGER Patents Act) Trade-related intellectual property policy/practices/encroachment by foreign countries/companies against U.S. competitiveness interests - China, Committee on Foreign Investment in the United States review of Chinese acquisitions and joint ventures, United States-Mexico-Canada Agreement IP chapter, International Trade Commission exclusion of U.S. patent-infringing imports, ITC baseband chip set patent infringement remedy, intellectual property exclusivity and protections in trade agreements Piracy of online and streaming copyrighted content Compulsory licensing - S. 377/H.R. 1046 (Medicare Negotiation and Competitive Licensing Act), S. 102/H.R. 465 (Prescription Drug Price Relief Act), S. 977 (Transparent Drug Pricing Act) NIST Return on Investment Initiative for Unleashing American Innovation S. 344/H.R. 990 (Hatch-Waxman Integrity Act) FTC/patent licensing as exclusive property right Bayh-Dole Act/technology transfer, march-in rights Procedural and evidentiary standards used at Patent Trial and Appeal Board PTO patentable subject matter eligibility guidance Section 101 patentable subject matter reform Injunctive relief from willful infringement DOJ-DOC withdrawal of 2013 Policy Statement on Remedies for Standards-Essential Patents Subject to Voluntary F/RAND Commitments S. 1273/H.R. 2426 (Copyright Alternative in Small-Claims Enforcement (CASE) Act) S. 1416 (Affordable Prescriptions for Patients Act) Obviousness/No Combination Drug Patents Act H.R. 4398/H.R. 5133 (Affordable Prescriptions for Patients Through Promoting Competition Act) H.R. 3991 (Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act) H.R. 5478 (Inventor Rights Act) Patent licensing/standards-essential patents/U.S. technological leadership in 5G and other technologies/economic and national security implications DOJ-PTO-NIST 2019 revised Joint Statement on Remedies for Standards-Essential Patents Subject to Voluntary F/RAND Commitments Efficient infringement Digital Millennium Copyright Act modernization Patent Trial & Appeal Board Covered Business Methods program PTAB Rules of Practice for Instituting on All Challenged Patent Claims and All Grounds and Eliminating the Presumption at Institution Favoring Petitioner as to Testimonial Evidence (Docket No. PTO-P-2019-0024) S. 3630 (Facilitating Innovation to Fight Coronavirus Act) Denial of rights of exclusivity for COVID-19-related innovations H.R. 7366 (Restoring Americas Leadership in Innovation Act) S. 3835 (SCRIPT Act) Proposed policy requiring privately produced, privately funded, copyrighted, peer-reviewed journal articles be given away free upon publication if they discuss any underlying research supported by a government grant Patent Trial and Appeal Board Covered Business Methods program statutory expiration Amendments to the Rules of Practice for Trials Before the Patent Trial and Appeal Board (RIN:0651-AD47)
2020 · second_quarter · Pharmacy
Implementation of Food and Drug Administration Reauthorization Act (FDARA). FDA Inspections. FDA Enforcement Discretion. Consent to FDA Approval. Generic Drug User Fee Amendments (GDUFA). Biosimilar User Fee Act (BsUFA). Labeling of Generic Drugs and Biosimilars. Country of Manufacture Labeling. S.3537: A bill to require the Secretary of Health and Human Services to maintain a list of the country of origin of all drugs marketed in the United States, to ban the use of Federal funds for the purchase of drugs manufactured in China, and for other purposes. S.3538: A bill to require the Secretary of Defense to submit to Congress a report on the reliance by the Department of Defense on imports of certain pharmaceutical products made in part or in whole in certain countries, to establish postmarket reporting requirements for pharmaceuticals, and for other purposes. Continuous Manufacturing. Approval of Supplements to ANDA Changing Manufacturing Locations. Drug Shortages. S.2723: Mitigating Emergency Drug Shortages Act. H.R.4398: Affordable Prescriptions for Patients Through Promoting Competition Act of 2019. Biosimilars Naming. Biosimilars Insulin. Pass Through Payments for Biosimilars. Cost Sharing for Biosimilars. H.R.4455: BIOSIM Act. H.R.4597: Acting to Cancel Copays and Ensure Substantial Savings for Biosimilars Act of 2019. H.R.4629: Star Rating for Biosimilars Act. Prescription Drug Costs. Drug Pricing. American Patients First: The Trump Administration Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. H.R.4913: To amend title XVIII of the Social Security Act to require PDP sponsors of a prescription drug plan under part D of the Medicare program that use a formulary to include certain generic drugs and biosimilar biological products on such formulary, and for other purposes. 180-Day Exclusivity. S.2543: Prescription Drug Pricing Reduction Act (PDPRA) of 2019. H.R.938: Bringing Low-Cost Options and Competition while Keeping Incentives for New Generics (BLOCKING) Act of 2019. H.R.465/S.102: Prescription Drug Price Relief Act of 2019. H.R.3: Lower Drug Costs Now Act of 2019. S.1895: Lower Health Care Costs Act. Reciprocal Marketing Authorization. Risk Evaluation and Mitigation Strategies (REMS). Pharmaceutical Exclusivity. 30-Month Stays. S.659: Biologic Patent Transparency Act. Biologics Price Competition and Innovation Act (BPCIA). Purple Book Modernization. Orange Book. Issues Related to COVID-19. Implementation of H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act. Implementation of H.R.6201: Families First Coronavirus Response Act. Implementation of S.3630: Facilitating Innovation to Fight Coronavirus Act. Rubio Coronavirus Plan. Commission on Americas Medical Security Act. Buy American Proposals. Buy American Executive Order. S.3478: A bill to require a report to assess, evaluate, and address the dependence of the United States on critical drugs and devices sourced or manufactured outside of the United States.
2020 · second_quarter · Copyright/Patent/Trademark
H.R. 987: Strengthening Health Care and Lowering Prescription Drug Costs Act - Provisions related to prescription drug pricing, patent settlements, and other issues H.R. 2700: Lowering Prescription Drug Costs and Extending Community Health Centers and Other Public Health Priorities Act - Provisions related to patent settlements, generic exclusivity, Risk Evaluation and Mitigation Strategies (REMS) and limited distribution systems H.R. 3666: STRONGER Patents Act of 2019 - Provisions related to prescription drug patents H.R. 6196: Trademark Modernization Act of 2020 - Provisions related to trademarks S. 2814: Patents for Humanity Program Improvement Act - Provisions related to certificates S. 3449: Trademark Modernization Act of 2020 - Provisions related to trademarks S. 3630: Facilitating Innovation to Fight Coronavirus Act - Provisions on patent terms Biopharmaceutical innovation and patent policy issues Trademark legislative proposals Bayh-Dole march-in rights policy issues
Client expense: $870,000 · Firm income: Not reported
2020 · second_quarter · Copyright/Patent/Trademark
H.R. 987: Strengthening Health Care and Lowering Prescription Drug Costs Act - Provisions related to prescription drug pricing, patent settlements, and other issues H.R. 2700: Lowering Prescription Drug Costs and Extending Community Health Centers and Other Public Health Priorities Act - Provisions related to patent settlements, generic exclusivity, Risk Evaluation and Mitigation Strategies (REMS) and limited distribution systems H.R. 3666: STRONGER Patents Act of 2019 - Provisions related to prescription drug patents H.R. 6196: Trademark Modernization Act of 2020 - Provisions related to trademarks S. 3449: Trademark Modernization Act of 2020 - Provisions related to trademarks S. 3630: Facilitating Innovation to Fight Coronavirus Act - Provisions on patent terms Biopharmaceutical innovation and patent policy issues Trademark legislative proposals Bayh-Dole march-in rights policy issues
Client expense: $5,410,000 · Firm income: Not reported
2020 · second_quarter · Medical/Disease Research/Clinical Labs
issues related to Medical Malpractice; issues related to business interruption insurance; issues related to pandemic liability immunity; HR 748; S.3648 HR 6800; S. 3630; HR 6664; HR 6601; HR 6283; HR 6359; S. 1350; S.3548.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · second_quarter · Small Business
issues related to Medical Malpractice; issues related to business interruption insurance; issues related to pandemic liability immunity; HR 748; S.3648 HR 6800; S. 3630; HR 6664; HR 6601; HR 6283; HR 6359; S. 1350; S.3548.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · second_quarter · Disaster Planning/Emergencies
issues related to Medical Malpractice; issues related to business interruption insurance; issues related to pandemic liability immunity; HR 748; S.3648 HR 6800; S. 3630; HR 6664; HR 6601; HR 6283; HR 6359; S. 1350; S.3548.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · second_quarter · Labor Issues/Antitrust/Workplace
S.306 - A bill to promote merger enforcement and protect competition through adjusting premerger filing fees, increasing antitrust enforcement resources, and improving the information provided to antitrust enforcers (Amy Klobuchar, D-MN) S.1978 - A bill to ensure that persons who form corporations or limited liability companies in the United States disclose the beneficial owners of those corporations or limited liability companies, in order to prevent wrongdoers from exploiting United States corporations and limited liability companies for criminal gain, to assist law enforcement in detecting, preventing, and punishing terrorism, money laundering, and other misconduct involving United States corporations and limited liability companies, and for other purposes (Ron Wyden, D-OR) H.R.2749 - To prohibit forced arbitration in work disputes, and for other purposes (Jerrold Nadler, D-NY-10) H.R.1423 - Forced Arbitration Injustice Repeal Act (Hank Johnson, Jr., D-GA-4) S.610 - Forced Arbitration Injustice Repeal Act (Richard Blumenthal, D-CT) H.R.2474 - Protecting the Right to Organize Act of 2019 (Robert Bobby Scott, D-VA-3) H.R.5712 - To repeal the authority under the National Labor Relations Act for States to enact laws prohibiting agreements requiring membership in a labor organization as a condition of employment, and for other purposes (Brad Sherman, D-CA-30) Senate Version: S.3255 - A bill to repeal the authority under the National Labor Relations Act for States to enact laws prohibiting agreements requiring membership in a labor organization as a condition of employment, and for other purposes (Elizabeth Warren, D-MA) H.R.6664 - To educate businesses on COVID-19 based public health practices, to provide for a notice and cure period before the commencement of a private civil action, and for other purposes (Tim Burchett, R-TN-2) S.3630 - A bill to provide certain limitations on liability for actions taken by health care providers to combat COVID-19 (Ben Sasse, R-NE) H.R.6844 - To provide expanded unemployment protection for employees and a limitation on liability for employers with respect to exposure to COVID-19 (Michael Turner, R-OH-10) H.R.6976 - To provide liability protection for nonprofit organizations during the COVID-19 outbreak, and for other purposes (Vicky Hartzler, R-MO-4) H.R.6909 - To provide for the establishment of a COVID-19 Compensation Fund, and for other purposes (Carolyn Maloney, D-NY-12) S.3915 - A bill to exempt certain businesses from liability arising from claims relating to an individual contracting COVID-19 as a result of patronizing a business or healthcare entity (Kelly Loeffler, R-GA) H.R.7179 - To provide liability protection for covered providers during the COVID-19 outbreak, and for other purposes (Gregory Murphy, R-NC-3) S.3941 - A bill to reopen the United States by rescinding, modifying, waiving, or providing exemptions from regulations and other requirements that may inhibit economic recovery from the COVID-19 pandemic, and for other purposes (Kelly Loeffler, R-GA) H.R.7266 - To prohibit COVID-19 liability waiver enforceability for large indoor gatherings (Mark Pocan, D-WI-2)
2020 · second_quarter · Copyright/Patent/Trademark
S. 2082/H.R. 3666 (STRONGER Patents Act) Trade-related intellectual property policy/practices/encroachment by foreign countries/companies against U.S. competitiveness interests - China, Committee on Foreign Investment in the United States review of Chinese acquisitions and joint ventures, United States-Mexico-Canada Agreement IP chapter, International Trade Commission exclusion of U.S. patent-infringing imports, ITC baseband chip set patent infringement remedy, intellectual property exclusivity and protections in trade agreements Piracy of online and streaming copyrighted content Compulsory licensing - S. 377/H.R. 1046 (Medicare Negotiation and Competitive Licensing Act), S. 102/H.R. 465 (Prescription Drug Price Relief Act), S. 977 (Transparent Drug Pricing Act) NIST Return on Investment Initiative for Unleashing American Innovation S. 344/H.R. 990 (Hatch-Waxman Integrity Act) FTC/patent licensing as exclusive property right Bayh-Dole Act/technology transfer, march-in rights Procedural and evidentiary standards used at Patent Trial and Appeal Board PTO patentable subject matter eligibility guidance Section 101 patentable subject matter reform Injunctive relief from willful infringement DOJ-DOC withdrawal of 2013 Policy Statement on Remedies for Standards-Essential Patents Subject to Voluntary F/RAND Commitments S. 1273/H.R. 2426 (Copyright Alternative in Small-Claims Enforcement (CASE) Act) S. 1416 (Affordable Prescriptions for Patients Act) Obviousness/No Combination Drug Patents Act H.R. 4398/H.R. 5133 (Affordable Prescriptions for Patients Through Promoting Competition Act) H.R. 3991 (Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act) H.R. 5478 (Inventor Rights Act) Patent licensing/standards-essential patents/U.S. technological leadership in 5G and other technologies/economic and national security implications DOJ-PTO-NIST 2019 revised Joint Statement on Remedies for Standards-Essential Patents Subject to Voluntary F/RAND Commitments Efficient infringement Digital Millennium Copyright Act modernization Patent Trial & Appeal Board Covered Business Methods program PTAB Rules of Practice for Instituting on All Challenged Patent Claims and All Grounds and Eliminating the Presumption at Institution Favoring Petitioner as to Testimonial Evidence (Docket No. PTO-P-2019-0024) S. 3630 (Facilitating Innovation to Fight Coronavirus Act) Denial of rights of exclusivity for COVID-19-related innovations H.R. 7366 (Restoring Americas Leadership in Innovation Act)
Government targets: Federal Housing Finance Agency (FHFA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
Government targets: Federal Housing Finance Agency (FHFA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
Government targets: Federal Housing Finance Agency (FHFA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Client expense: $550,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Highway Traffic Safety Administration (NHTSA), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Council on Environmental Quality (CEQ), Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE
Client expense: $850,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR)
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Economic Council (NEC), Natl Institutes of Health (NIH), Office of the Vice President of the United States, Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Client expense: $550,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Highway Traffic Safety Administration (NHTSA), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
Client expense: Not reported · Firm income: $10,000
Government targets: Council on Environmental Quality (CEQ), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Patent & Trademark Office (PTO), SENATE